Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with Neurofibromatosis Type 1 (NF1), a genetic condition that causes tumors to grow on nerve tissue, based on specific updated diagnostic guidelines from 2021
- People who have a history of plexiform neurofibromas (a type of tumor associated with NF1 that grows along nerves)
- People who are able to read and understand English or Spanish
- People who currently live in the USA
Who may not be able to join:
- People under the age of 18
- People who do not have a diagnosis of NF1
- People who have no history or evidence of plexiform neurofibromas
- People who are not able to read or understand either English or Spanish
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David T Miller, MD, PhD, Boston Children's Hospital
Phone: 617-355-8221
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Timing of MPNST detection by liquid biopsy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.